Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 27, 2015 9:59 AM ET

Capital Markets

Company Overview of Wellcome Trust, Investment Division

Company Overview

Wellcome Trust, Investment Division is a private equity and venture capital firm specializing in equity financing in early stage companies, buyouts, absolute returns, and emerging markets. The firm also invests in venture capital funds and buyouts funds and also selectively invests in later-stage private companies. It prefers to invest in healthcare, life sciences, therapeutics, technologies, medical devices, financial services, and energy space. The firm typically invests in U.S. and Europe. It seeks to invest up to £10 million ($18.82 million) over the life of a company through initial and follow-on financings. The firm usually invests alongside venture capitalists that are represented on ...

215 Euston Road

Gibbs Building

London,  NW1 2BE

United Kingdom

Phone:

44 20 7611 8888

Fax:

44 20 7611 8545

Key Executives for Wellcome Trust, Investment Division

Chief Executive of Project Sigma
Managing Director and Member of Investment Committee
Chief Investment Officer and Member of Investment Committee
Age: 50
Investment Adviser
Compensation as of Fiscal Year 2014.

Wellcome Trust, Investment Division Key Developments

H. Lundbeck A/S Announces Research Partnership for Treatment of Brain Diseases Involving Seven Universities

H. Lundbeck A/S has announced a new public-private partnership involving seven universities, for the treatment of brain diseases. Lundbeck is involved in new research that will investigate a novel link that could show a relationship between the immune system and mood disorders, such as depression, and neurodegenerative diseases, such as Alzheimer's disease. This project, a public-private partnership also involving The Wellcome Trust, Cambridge University and pharmaceutical company Janssen, may be the first step towards a new and significantly improved treatment for a broad range of brain diseases. The main theory that the project will investigate is that the immune system can worsen brain diseases like depression and Alzheimer's disease. An imbalance in the immune system of the brain can drive a permanent and unhealthy neuro-inflammation - or inflammation in the brain - that can contribute to or cause brain diseases. This new project is a public-private partnership between Lundbeck and Janssen, and seven universities. The project has received a strategic award valued at approximately DKK 50m from the Wellcome Trust. The project consists of two parts. The team will begin by investigating the immune systems of people with treatment-resistant depression and Alzheimer's disease. In this phase, researchers will seek to more precisely establish the relationship between immune-related biomarkers found in blood and brain including cytokines, which are small proteins that play an important role in the regulation of the immune responses. The second part of the research program, which is reliant on the success of the first, will focus on small experimental medicine trials, using re-purposed anti-inflammatory drugs in patients who have been identified according to their specific immunological profile or 'phenotype'.

Wellcome Trust, Investment Division Presents at The 12th SPS Private Equity Investors Annual Conference, Jan-15-2015 03:30 PM

Wellcome Trust, Investment Division Presents at The 12th SPS Private Equity Investors Annual Conference, Jan-15-2015 03:30 PM. Venue: Le Meridien Piccadilly, London, United Kingdom. Speakers: Robert Coke, Team Head.

THE WELLCOME TRUST Presents at The 13th Annual SuperInvestor 2013, Nov-20-2013 11:30 AM

THE WELLCOME TRUST Presents at The 13th Annual SuperInvestor 2013, Nov-20-2013 11:30 AM. Venue: The Westin Hotel, 3 Rue De Castiglione, Paris 75001, France. Speakers: Peter Pereira Gray, Head of Investments.

Similar Private Companies By Industry

Company Name Region
Megabuyte Europe
Grand Union Group Funding PLC Europe
Jones Lang LaSalle Hotels Limited Europe
WestPoint Financial Consultants Ltd Europe
Higham Financial Services Limited Europe

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
February 27, 2015
Optos plc
Merger/Acquisition
February 11, 2015
GlycoVaxyn AG
Private Placement
January 12, 2015
Verne Global, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Wellcome Trust, Investment Division, please visit www.wellcome.ac.uk/Investments/index.htm. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.